These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 17148690)
1. Modulation of the IL-12/IFN-gamma axis by IFN-alpha therapy for hepatitis C. Byrnes AA; Li DY; Park K; Thompson D; Mocilnikar C; Mohan P; Molleston JP; Narkewicz M; Zhou H; Wolf SF; Schwarz KB; Karp CL J Leukoc Biol; 2007 Mar; 81(3):825-34. PubMed ID: 17148690 [TBL] [Abstract][Full Text] [Related]
2. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha. Alvarado Esquivel C; Elewaut A; Philippé J; Elewaut AE; Desombere I; Maertens G; Leroux-Roels G Rev Invest Clin; 2002; 54(1):41-50. PubMed ID: 11995406 [TBL] [Abstract][Full Text] [Related]
3. Impaired ability of interferon-alpha-primed dendritic cells to stimulate Th1-type CD4 T-cell response in chronic hepatitis C virus infection. Miyatake H; Kanto T; Inoue M; Sakakibara M; Kaimori A; Yakushijin T; Itose I; Miyazaki M; Kuzushita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N J Viral Hepat; 2007 Jun; 14(6):404-12. PubMed ID: 17501761 [TBL] [Abstract][Full Text] [Related]
4. [Effect of IL-12 on IFN-gamma and IL-10 produced by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection during IFN-alpha treatment]. Wang S; Lin Y; Ma W; Zhang B; Qi S; Lan F Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):116-9. PubMed ID: 11983129 [TBL] [Abstract][Full Text] [Related]
5. The levels of IL-1 nu beta, IL-2, IL-4, IL-6 and IFN-gamma among patients with chronic hepatitis type C treated with IFN-alpha. Łapiński TW Rocz Akad Med Bialymst; 2000; 45():211-27. PubMed ID: 11712433 [TBL] [Abstract][Full Text] [Related]
6. Interferon-alpha therapy does not modulate hepatic expression of classical type I interferon inducible genes. Meier V; Mihm S; Ramadori G J Med Virol; 2008 Nov; 80(11):1912-8. PubMed ID: 18814253 [TBL] [Abstract][Full Text] [Related]
7. Chronic hepatitis C and persistent occult hepatitis C virus infection are characterized by distinct immune cell cytokine expression profiles. Pham TN; Mercer SE; Michalak TI J Viral Hepat; 2009 Aug; 16(8):547-56. PubMed ID: 19215578 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-12 p40/p70 ratio and in vivo responsiveness to IFN-alpha treatment in chronic hepatitis C. Piazzolla G; Tortorella C; Fiore G; Fanelli M; Pisconti A; Antonaci S J Interferon Cytokine Res; 2001 Jul; 21(7):453-61. PubMed ID: 11506737 [TBL] [Abstract][Full Text] [Related]
9. Interferon alfa subtypes and levels of type I interferons in the liver and peripheral mononuclear cells in patients with chronic hepatitis C and controls. Castelruiz Y; Larrea E; Boya P; Civeira MP; Prieto J Hepatology; 1999 Jun; 29(6):1900-4. PubMed ID: 10347136 [TBL] [Abstract][Full Text] [Related]
10. Direct evidence for immunomodulatory properties of ribavirin on T-cell reactivity to hepatitis C virus. Rigopoulou EI; Abbott WG; Williams R; Naoumov NV Antiviral Res; 2007 Jul; 75(1):36-42. PubMed ID: 17210188 [TBL] [Abstract][Full Text] [Related]
11. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment. Gonzalez VD; Falconer K; Björkström NK; Blom KG; Weiland O; Ljunggren HG; Alaeus A; Sandberg JK J Immunol; 2009 Nov; 183(10):6612-8. PubMed ID: 19846870 [TBL] [Abstract][Full Text] [Related]
12. [Level of the cytokine secreted by periferal blood mononuclear cells in patients with chronic hepatitis C before antiviral therapy]. Dong Y; Zhang HF; Chen H; Li J; Yang XJ; Zhu SS; Cheng Y Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):364-6. PubMed ID: 19469176 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production. Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575 [TBL] [Abstract][Full Text] [Related]
14. Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease. Gigi E; Raptopoulou-Gigi M; Kalogeridis A; Masiou S; Orphanou E; Vrettou E; Lalla TH; Sinakos E; Tsapas V J Viral Hepat; 2008 Feb; 15(2):145-54. PubMed ID: 18184198 [TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma: biologic functions and HCV terapy (type I/II) (2 of 2 parts). Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R Clin Ter; 2006; 157(5):457-68. PubMed ID: 17147054 [TBL] [Abstract][Full Text] [Related]
16. Effects of IL-12 and IL-18 on HBcAg-specific cytokine production by CD4 T lymphocytes of children with chronic hepatitis B infection. Szkaradkiewicz A; Jopek A; Wysocki J Antiviral Res; 2005 Apr; 66(1):23-7. PubMed ID: 15781128 [TBL] [Abstract][Full Text] [Related]
17. [Cytokine spectrum in patients with chronic hepatitis C in the treatment with interferon-alpha drugs]. Sobchak DM; Korochkina OV; Monakova EA Ter Arkh; 2005; 77(2):70-2. PubMed ID: 15807457 [TBL] [Abstract][Full Text] [Related]
18. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8. Jia Y; Wei L; Jiang D; Wang J; Cong X; Fei R J Gastroenterol Hepatol; 2007 Aug; 22(8):1278-85. PubMed ID: 17565587 [TBL] [Abstract][Full Text] [Related]
19. Effect of pentoxifylline on levels of pro-inflammatory cytokines during chronic hepatitis C. Gutierrez-Reyes G; Lopez-Ortal P; Sixtos S; Cruz S; Ramirez-Iglesias MT; Gutierrez-Ruiz MC; Sanchez-Avila F; Roldan E; Vargas-Vorackova F; Kershenobich D Scand J Immunol; 2006 Jun; 63(6):461-7. PubMed ID: 16764700 [TBL] [Abstract][Full Text] [Related]
20. Recovery of IFN-gamma levels in PBMCs from lepromatous leprosy patients through the synergistic actions of the cytokines IL-12 and IL-18. Lopez Roa RI; Guerrero Velásquez C; Alvarado Navarro A; Montoya Buelna M; Garcia Niebla C; Fafutis Morris M Int Immunopharmacol; 2008 Dec; 8(13-14):1715-20. PubMed ID: 18708162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]